469 related articles for article (PubMed ID: 32982219)
1. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
[TBL] [Abstract][Full Text] [Related]
2. Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy.
Zhang L; Wu S; Qin Y; Fan F; Zhang Z; Huang C; Ji W; Lu L; Wang C; Sun H; Leng X; Kong D; Zhu D
Nano Lett; 2019 Jul; 19(7):4237-4249. PubMed ID: 30868883
[TBL] [Abstract][Full Text] [Related]
3. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8
Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y
Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032
[TBL] [Abstract][Full Text] [Related]
4. Mannose-functionalized "pathogen-like" polyanhydride nanoparticles target C-type lectin receptors on dendritic cells.
Carrillo-Conde B; Song EH; Chavez-Santoscoy A; Phanse Y; Ramer-Tait AE; Pohl NL; Wannemuehler MJ; Bellaire BH; Narasimhan B
Mol Pharm; 2011 Oct; 8(5):1877-86. PubMed ID: 21882825
[TBL] [Abstract][Full Text] [Related]
5. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
[TBL] [Abstract][Full Text] [Related]
6. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
Torres MP; Wilson-Welder JH; Lopac SK; Phanse Y; Carrillo-Conde B; Ramer-Tait AE; Bellaire BH; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2011 Jul; 7(7):2857-64. PubMed ID: 21439412
[TBL] [Abstract][Full Text] [Related]
7. Antigen Delivery to DEC205
Silva MO; Almeida BS; Sales NS; Diniz MO; Aps LRMM; Rodrigues KB; Silva JR; Moreno ACR; Porchia BFMM; Sulczewski FB; Boscardin SB; Ferreira LCS
Int J Biol Sci; 2021; 17(11):2944-2956. PubMed ID: 34345218
[TBL] [Abstract][Full Text] [Related]
8. Pentaerythritol-based lipid A bolsters the antitumor efficacy of a polyanhydride particle-based cancer vaccine.
Wafa EI; Geary SM; Ross KA; Goodman JT; Narasimhan B; Salem AK
Nanomedicine; 2019 Oct; 21():102055. PubMed ID: 31319179
[TBL] [Abstract][Full Text] [Related]
9. Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity.
Hong E; Usiskin IM; Bergamaschi C; Hanlon DJ; Edelson RL; Justesen S; Pavlakis GN; Flavell RA; Fahmy TM
J Biol Chem; 2016 Apr; 291(17):8931-50. PubMed ID: 26719339
[TBL] [Abstract][Full Text] [Related]
10. Carbomer-based adjuvant elicits CD8 T-cell immunity by inducing a distinct metabolic state in cross-presenting dendritic cells.
Lee W; Kingstad-Bakke B; Paulson B; Larsen A; Overmyer K; Marinaik CB; Dulli K; Toy R; Vogel G; Mueller KP; Tweed K; Walsh AJ; Russell J; Saha K; Reyes L; Skala MC; Sauer JD; Shayakhmetov DM; Coon J; Roy K; Suresh M
PLoS Pathog; 2021 Jan; 17(1):e1009168. PubMed ID: 33444400
[TBL] [Abstract][Full Text] [Related]
11. Liposomes-coated gold nanocages with antigens and adjuvants targeted delivery to dendritic cells for enhancing antitumor immune response.
Liang R; Xie J; Li J; Wang K; Liu L; Gao Y; Hussain M; Shen G; Zhu J; Tao J
Biomaterials; 2017 Dec; 149():41-50. PubMed ID: 28992509
[TBL] [Abstract][Full Text] [Related]
12. Methods of effective conjugation of antigens to nanoparticles as non-inflammatory vaccine carriers.
Xiang SD; Wilson K; Day S; Fuchsberger M; Plebanski M
Methods; 2013 May; 60(3):232-41. PubMed ID: 23643867
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.
Grossmann C; Tenbusch M; Nchinda G; Temchura V; Nabi G; Stone GW; Kornbluth RS; Uberla K
BMC Immunol; 2009 Aug; 10():43. PubMed ID: 19650904
[TBL] [Abstract][Full Text] [Related]
14. Polyanhydride nanovaccine against swine influenza virus in pigs.
Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
[TBL] [Abstract][Full Text] [Related]
15. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons.
Sun S; Zhang X; Tough D; Sprent J
Springer Semin Immunopathol; 2000; 22(1-2):77-84. PubMed ID: 10944802
[TBL] [Abstract][Full Text] [Related]
16. Conventional dendritic cells are required for the activation of helper-dependent CD8 T cell responses to a model antigen after cutaneous vaccination with lentiviral vectors.
Goold HD; Escors D; Conlan TJ; Chakraverty R; Bennett CL
J Immunol; 2011 Apr; 186(8):4565-72. PubMed ID: 21389256
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
[TBL] [Abstract][Full Text] [Related]
18. Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Broderick S; Pohl N; Rajan K; Narasimhan B; Wannemuehler MJ; Bellaire BH
J Biomed Mater Res A; 2017 Oct; 105(10):2762-2771. PubMed ID: 28556563
[TBL] [Abstract][Full Text] [Related]
19. Messenger RNA-based vaccines with dual activity induce balanced TLR-7 dependent adaptive immune responses and provide antitumor activity.
Fotin-Mleczek M; Duchardt KM; Lorenz C; Pfeiffer R; Ojkić-Zrna S; Probst J; Kallen KJ
J Immunother; 2011 Jan; 34(1):1-15. PubMed ID: 21150709
[TBL] [Abstract][Full Text] [Related]
20. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
Wang J; Saffold S; Cao X; Krauss J; Chen W
J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]